LATEST ALERTS
Firms from Israel and South America are showing faith in the European CBD market, and its bricks-and-mortar retail, with distribution deals to place their products in a growing number of outlets
Global agricultural giant Pyxus International is among a number of international companies that have expressed interest in venturing into hemp cultivation in Malawi
A TV advertising campaign has significantly boosted sales for a CBD drinks company and it hopes a new listing in a high-end chain of UK supermarkets will consolidate those gains
It remains unclear where the hemp and CBD investment centre for Asia will develop. History and existing infrastructure would point to Hong Kong, but development there has stalled – and there are other contenders
Enforcement activity against food, drink and dietary supplement products placed on the market containing CBD continues despite the inability of companies to proceed with novel food applications due to the EC’s questions over whether CBD constitutes a narcotic under the 1961 UN Single Convention on Narcotics.
Hard-hit cannabinoid firms in the US and Canada are reassessing their market strategies, restructuring, and downsizing – in some cases with significant job cuts – as the market remains volatile
Several major developments have all happened at the same time for novel foods. Perhaps most importantly, one of the European Commission’s departments – the Directorate-General for Health and Food Safety – has said it is holding sending any further non-synthetic CBD applications to the European Food Safety Authority for evaluation until it has determined whether CBD technically falls under the definition of a narcotic according to the 1961 UN Single Convention on Narcotic Drugs.
This report investigates the current situation with respect to advertising CBD products via the most widely used social media platforms
A strong online presence has been essential to resiliency through the COVID-19 pandemic, but many larger offline retail chains that have also focused on selling through these channels may still see a recovery
The loss of conferences and expos due to COVID-19 prevention measures has not affected the sale of white label goods as much as may have been anticipated, according to companies
CBD companies are in a fairly unique place in that they cannot use their primary function – health and wellness – to advertise their brands. And this is not without reason – as shown by the numerous instances of scurrilous companies making outlandish claims about CBD and cancer, Alzheimer’s and other diseases where a “miracle cure” is seemingly often the last chance of the desperate.
In a case that illustrates difficulties a number of CBD businesses have encountered in reaching their target market, a CBD company in the US is suing a TV advertising firm, alleging deceptive trade practices and breach of contract
A new line of sparkling CBD drinks is to be launched in the Colorado market in what may be an indication of how high-profile companies approach the CBD market during its continued period of uncertainty
A new CBD brand from British Cannabis is hitting the UK market at a significantly lower price point than any previously seen
Major French flavours and fragrance manufacturer Robertet is making its first foray into European cultivation and processing of hemp oil extracts in a joint venture with Swiss CBD and hemp producer Alponics
Canadian grower Beleave has become the latest casualty of turbulent times in the cannabis industry
One of the most iconic brands in the cannabis space, High Times, has entered into an agreement with Red White & Bloom (RWB) to develop cannabis-based CBD and THC products across the US
Subscription services are a niche area of the CBD market that could benefit from the ongoing COVID-19 pandemic, providing companies with security and customers with a way to try new products without leaving home
A CBD oil made by Brazilian drugs company Prati-Donaduzzi could become the biggest-selling cannabinoid product on the Brazilian market
Excess production space, surplus of supply, legal restrictions – and now the coronavirus crisis – have been giving the global cannabis industry a tough ride and some businesses are setting their sights on hemp-derived CBD
Zimbabwe has changed tack, allowing investors to hold 100% of medicinal cannabis licences in order to improve competiveness of the sector both regionally and globally
The public prosecutor’s office in Parma has suspended all commercial operations of Italy’s leading CBD company, EasyJoint, pending trial on narcotics charges
Artemis Growth Partners will look to use the new purchase of a UK farming complex to feed its international CBD supply chain before potentially creating a separate CBD brand and move into medical cannabis supply
Countries in South America are becoming increasingly important markets for CBD, as the ink dries on a deal to distribute medical cannabis products in Brazil, where a change in regulatory policy has opened up trade
Former supermodel Kathy Ireland looks set to finally launch a range of CBD products after two prior relationships never developed beyond the prototype and testing phase
Canadian cannabis firm Aurora has shifted focus to the US CBD market, a long-time goal of the company, with the $40m purchase of retailer Reliva
The company behind the world’s first injectable CBD product has issued a voluntary recall, while the US FDA continues to send warning letters over unsubstantiated health claims
A $77m deal with creditors to purchase GenCanna as a going concern looks unlikely to be the final step in an ongoing bankruptcy drama surrounding one of the US’s largest hemp processing companies
Volatility in the CBD sector continues with two major companies being granted protection by Canadian courts
The US National Advertising Division (NAD) has criticised certain cosmetic and wellness products for not containing as much CBD as claimed on their packaging
A Canadian company part-owned by singer Bif Naked has run foul of Canada’s national health authority after suggesting its CBD products can help protect users from COVID-19
CBD companies in the US that deal in THC may not be able to take Chapter 11 bankruptcy – reorganisation as a going concern – leaving those reliant on the business and creditors with few other options
Chinese companies hoping to build up CBD businesses are growing increasingly frustrated by a lack of rulemaking, which is inhibiting the development of the domestic market
Operations of Canopy Growth’s African subsidiary have not been affected by the parent company’s decision to pull out and leave things in local hands – according to the man in charge of those local hands. Jody Aufrichtig, head of Canopy Growth Africa, told CBD-Intel he did not anticipate any disruption from the divestment and transfer of ownership. Canadian company Canopy » Continue Reading.
The US Federal Trade Commission (FTC) has taken further steps in the fight against CBD brands making unsubstantiated medical claims, with one hit with a restraining order and injunction
Corporate interest in smokable hemp as a consumer product continues to grow in the US despite the mixed and sometimes unclear regulatory situation
Initial reports on the results of the first ever socially distanced 4/20 are a mixed bag
Further legal action is expected from the only company so far granted official permission to grow hemp in Brazil after a federal court suspended its authorisation
Supply agreements for CBD continue to develop in South America, with new deals for distributing products in Brazil and an agreement in Colombia brought about by Canopy Growth’s change in strategy
While the global coronavirus epidemic and consequent lockdown have caused uncertainty in the cannabis sector, investments in CBD are likely to go ahead in the coming months, some experts in the industry say
Finnish authorities have cracked down on domestically based companies selling dietary supplements containing CBD, which they say lack EU authorisation, leading one of the largest importer of supplements to file for bankruptcy
Continued investment and a number of minor launches suggest a CBD beverage from one of the major drinks players in North America may not be far off
CBD companies have had to adapt marketing strategies as the COVID-19 pandemic has developed. The pandemic and the associated practice of social distancing have overtaken 4/20, the biggest promotional day for cannabis
Companies that have made claims about CBD’s beneficial effects against COVID-19 are facing swift enforcement action from US regulatory authorities
CBD entrepreneur Christina DiArcangelo tells CBD-Intel that businesses should be using the slowdown to study, reflect, plan – and “get ahead of the ball”
The wider impact of COVID-19 on the CBD sector in the US remains confused in the short term and largely a mystery in the longer term as companies scramble to gather information
Also: Drug mart deal for CBD on prescription; A little hemp in your tea, sir?; Celebrity cook denies endorsing CBD; Convenience store chain to sell CBD snacks; UK firm launches CBG hand cleanser; CBD products on Circle K shelves; Hawaii distribution deal
Two companies have independently come up with the same general solution to major CBD problems. Micelle encapsulation replicates the body’s normal internal process of absorbing fats. The process used by the companies encapsulates CBD in micelles
CBD companies continue to struggle to deliver returns to investors, with two major Californian firms reporting overall losses despite some positives
Also: £500k funding for online retailer; Hollister picks magic mushroom researchers; KushCo scales back trading prediction; HempNova prepares to grow and process in Oregon
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Notifications
